Johnson & Johnson-AESA Research & Development (R&D) Fellowship Programme 2020

0
426

Application Deadline:Friday, July 31, 2020

Johnson & Johnson and the African Academy of Sciences (AAS), with the support of the Johnson & Johnson Foundation, are committed to address this gap, by building drug development capacity and networks in Africa to enable countries to address diseases with high medical needs, locally. Through the establishment of a Research and Development (R&D) training fellowship programme for highly talented, suitably qualified and experienced African physicians, pharmacists, epidemiologists and/or MSc’s in public health to help close the R&D knowledge and experience gap that exists in many African countries.

This fellowship programme is managed by the Alliance for Accelerating Excellence in Science in Africa (AESA) is an Africa-led, Africa-centred, and Africa-specific funding and agenda setting platform created to accelerate scientific excellence, leadership and innovation.  AESA is an initiative of the African Academy of Sciences (AAS) and the New Partnership for Africa’s Development (NEPAD) Agency. 

Within this fellowship programme, Johnson & Johnson, through its dedicated Global Public Health organization, together with the selected Fellows, consider the specific needs of the countries of origin and build upon the valuable knowledge which the fellows bring to the programme to optimize the course curriculum. The majority of the 2-year training will be ‘on the job’ when fellows are being assigned to a late-stage development programme at Johnson & Johnson’s Janssen Pharmaceutical Companies, primarily in areas of infectious diseases, neglected tropical diseases, and vaccines. In addition, the training shall comprise of:

  1. Training modules on all aspects of drug development with focus on clinical development;
  2. Training modules in leadership, communication, project management, etc. to strengthen leadership skills;
  3. Selective modules of the master programmes of Public Health or Tropical Medicine at the Institute of Tropical Medicine, Antwerp;
  4. Other opportunities as identified during the programme (conferences, other trainings).

Requirements

Individual

  1. A citizen of any of the sub-Saharan African countries listed here: Botswana, Burkina Faso, Burundi, Chad, Côte d’Ivoire, Democratic Republic of Congo, Gabon, Lesotho, Madagascar, Malawi, Mali, Mauritius, Namibia, Niger, Nigeria, Republic of Congo, Rwanda, Swaziland, Senegal, Zambia and Zimbabwe;
  2. Employed in public, not-for-profit, or academic institutions, or industry;
  3. Holding of a scientific University degree (PhD, MD, physicians, pharmacists, epidemiologists, relevant master’s qualifications) with high interest to expand knowledge and experience in drug development and clinical development;
  4. Holding a degree and / or demonstrated experience in Public Health and/or local healthcare;
  5. Aged between 30 and 45 years at the time of application.

Institution

  1. Is a legal entity;
  2. Is based in a sub-Saharan African country listed here: Botswana, Burkina Faso, Burundi, Chad, Côte d’Ivoire, Democratic Republic of Congo, Gabon, Lesotho, Madagascar, Malawi, Mali, Mauritius, Namibia, Niger, Nigeria, Republic of Congo, Rwanda, Swaziland, Senegal, Zambia and Zimbabwe.

Fellowship Details

Purpose

The Johnson & Johnson-AESA R&D fellowship programme is committed to building drug development capacity and networks in Africa to enable countries to address diseases with high medical needs, locally. In that spirit, Johnson & Johnson has established an R&D Training Fellowship Programme for highly talented, suitably qualified and experienced African doctors and scientists, to help close the R&D knowledge and experience gap that exists in many countries in Africa to be hosted by the AAS.

Year 2-3 | Return to home country in Africa

The AAS and Johnson & Johnson will support the fellows for a 1-year period on their return to their home country. Elements of this support may include:

  1. Training materials for academic teaching, capacity building and networks.
  2. Clinical trial expertise to support initiation of local clinical research.
  3. Evaluate opportunities and feasibility of institution to participate in international development programmes and networks

Monitoring

A Steering Committee is established for every fellow to monitor progress through the Programme. The committee includes the representatives of the AAS, Johnson & Johnson and of the institutes in the fellow’s home country and will:

  1. Discuss Fellow’s practical arrangements in the hosting country and find solutions for any existing or potential future anticipated issues;
  2. Discuss Fellow’s integration into Johnson & Johnson teams and find solutions for any existing or potential future anticipated issues;
  3. Consider any adjustments to the course curriculum which may be deemed appropriate by the steering committee;
  4. Review current thinking on the proposed position in which the Fellow will be deployed upon repatriation, and post-training completion support.

For More Information:

Visit the Official Webpage of the Johnson & Johnson-AESA Research & Development (R&D) Fellowship Programme 2020

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.